Prevalence of medical marijuana use in <scp>C</scp>alifornia, 2012

Ryan-Ibarra, Suzanne; Induni, Marta; Ewing, Danielle

doi:10.1111/dar.12207

Cited by 66 publications

(64 citation statements)

References 25 publications

(42 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the Ware et al cohort, 35% of patients had previously used cannabis, and of those, 15% used it specifically for pain relief. Those data are corroborated by data from the California Behavior Risk Factor Surveillance System, which showed that 5% of telephone respondents reported medical marijuana use and that respondents who used tended to be younger and to have conditions such as chronic pain 7 . A survey of a mixed cohort of patients from the United Kingdom reported on the opinions of 2969 respondents about cannabis use between 1998 and 2002 9 .…”

Section: Discussionmentioning

confidence: 65%

Rates of Cannabis Use in Patients with Cancer

et al. 2018

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 65%

Rates of Cannabis Use in Patients with Cancer

et al. 2018

View full text Add to dashboard Cite

show abstract

“…To learn more about the use of medical marijuana, a question was added to the California version of the Behavioral Risk Factor Surveillance System telephone survey in 2012 and the results showed the prevalence of ever having used medical marijuana was highest among white adults and younger adults ages 18–24 (Ryan-Ibarra et al, 2015). …”

Section: Resultsmentioning

confidence: 99%

What Do We Know Now About the Impact of the Laws Related to Marijuana?

Maxwell

Mendelson

2016

Journal of Addiction Medicine

View full text Add to dashboard Cite

Objectives This paper presents information on the status and impact of medical and legalized marijuana as well as the latest data on attitudes and prevalence of use since implementation of these laws. Recent reports from epidemiologists in Denver and Seattle are summarized to give the readers a sense of the changes as these laws have taken effect in their communities. Methods The status of these laws is reviewed and the results of surveys taken before and after the laws were enacted are presented, along with data on changing potency and driving under the influence of marijuana. Summary Prevalence of use by youths has not increased but their negative attitudes towards the risk of using marijuana have decreased; use by adults has increased. Potency continues to increase, as has the proportion of drivers testing positive for use of the drug. Data from Denver show increases in hospital admissions, emergency department visits, and calls to poison centers, with decreasing arrests and admissions to substance abuse treatment programs. Data from the Seattle area show similar decreases in treatment admissions and police involvement, but also increased prevalence of more frequent use. Conclusions Current data suggest that increases in marijuana use preceded legalization in 2012. Treatment admissions were declining prior to these laws, but some indicators of morbidity appear to be increasing subsequent to legalization, with modest increases in poison center calls in both states and increases in acute medical visits in Denver. Data are needed to understand the relationship between the patterns and amounts of use in terms of consequences as well as data on the health conditions of those receiving medical marijuana and the impact of higher potency.

show abstract

“…Considering the fact that illicit market purchase behaviors differ by demographics, medical marijuana purchase behaviors might differ by patient demographic characteristics as well. In fact, trends of medical marijuana patients in California from 2001 to 2012 parallel high-quantity purchasers identified in illicit markets, both being predominantly men, young adults, and non-Hispanic Whites (O’Connell & Bou-Matar 2007; Ryan-Ibarra, Induni & Ewing 2014). …”

mentioning

confidence: 99%

“…Patients have primarily reported medical conditions of chronic pain, sleeping problems, and anxiety (O’Connell & Bou-Matar 2007; Ryan-Ibarra et al 2014). Among these patients, it is possible that including chronic pain as a qualifying condition for marijuana could have variable influences on effects of medical marijuana recommendation and distribution policies (Pacula et al 2015).…”

mentioning

confidence: 99%

Correlates of Amount Spent on Marijuana Buds During a Discrete Purchase at Medical Marijuana Dispensaries: Results from a Pilot Study

Kepple

Mulholland

Freisthler

et al. 2016

Journal of Psychoactive Drugs

View full text Add to dashboard Cite

Marijuana purchasing behaviors vary by the purchaser’s individual characteristics; however, little is known about patients’ purchasing behaviors when buying from medical marijuana dispensaries (MMDs). Our objective was to explore whether patient characteristics were associated with amount spent during one financial transaction at medical marijuana dispensaries. We conducted a pilot study of 4 purposively sampled MMD locations in Long Beach, California, in 2012. A total of 132 medical marijuana patients (33 patients per dispensary) participated in an exit survey about their demographic characteristics, conditions for their medical marijuana recommendation, amount spent at the dispensary, and cross-streets of where they lived. The sample reported amounts spent on discrete purchases of marijuana buds averaging $40.82 (ranging $10 to $255). Multivariate regression analyses indicated average amount spent differed significantly by patient age and condition. An increase in 10 years of age was associated with a 10% higher amount spent. Receiving a recommendation for anxiety and/or sleeping problems or other nonspecified conditions was related to higher discrete purchase amounts than chronic pain. This pilot suggests that variations in patient purchasing behaviors from MMDs exist. These purchase behaviors can provide insight into variations in how patients use dispensaries, consume products, and allocate personal resources.

show abstract

Prevalence of medical marijuana use in California, 2012

Cited by 66 publications

References 25 publications

Rates of Cannabis Use in Patients with Cancer

Rates of Cannabis Use in Patients with Cancer

What Do We Know Now About the Impact of the Laws Related to Marijuana?

Correlates of Amount Spent on Marijuana Buds During a Discrete Purchase at Medical Marijuana Dispensaries: Results from a Pilot Study

Contact Info

Product

Resources

About